Page 100 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 100
drome (plus urticaria)--1922 (with a 10. Yoshimine F, Hasegawa T, Suzuki E,
note on aspirin desensitization). By F. et al. Contribution of aspirin-intoler-
severe asthma forum 1: severe asthma - basic and clinical views Widal, P. Abrami, J. Lermoyez. J Asth- ant asthma to near fatal asthma based
ma. 1987;24(5):297-300. on a questionnaire survey in Niigata
2. Mascia K, Haselkorn T, Deniz YM, et Prefecture, Japan. Respirology. 2005
al. Aspirin sensitivity and severity of Sep;10(4):477-84.
asthma: evidence for irreversible airway
obstruction in patients with severe or 11. Kowalski ML. Heterogeneity of
difficult-to-treat asthma. J Allergy Clin NSAID-Exacerbated Respiratory Dis-
Immunol. 2005 Nov;116(5):970-5. ease: has the time come for subpheno-
3. Wöhrl S. NSAID hypersensitivity – rec- typing? Curr Opin Pulm Med. 2019
ommendations for diagnostic work up Jan;25(1):64-70.
and patient management. Allergo J Int.
2018;27(4):114-21. 12. Kowalski ML, Agache I, Bavbek S,
4. Blanca-Lopez N, Soriano V, Gar- et al. Diagnosis and management of
cia-Martin E, et al. NSAID-induced re- NSAID‐Exacerbated Respiratory Dis-
actions: Classification, prevalence, im- ease (N-ERD) – a EAACI position pa-
pact, and management strategies. J per. Allergy. 2019 Jan;74(1):28-39.
Asthma Allergy. 2019 Aug 8;12:217-33.
5. Kowalski ML, Asero R, Bavbek S, 13. Stevenson DD, White AA. Clinical
et al. Classification and practical ap- Characteristics of Aspirin-Exacerbated
proach to the diagnosis and manage- Respiratory Disease. Immunol Allergy
ment of hypersensitivity to nonsteroidal Clin North Am. 2016 Nov;36(4):643-
anti-inflammatory drugs. Allergy. 2013 55.
Oct;68(10):1219-32.
6. Modena B, White AA, Woessner KM. 14. Kennedy JL, Stoner AN, Borish L.
Aspirin and Nonsteroidal Antiinflam- Aspirin-exacerbated respiratory dis-
matory Drugs Hypersensitivity and ease: Prevalence, diagnosis, treat-
Management. Immunol Allergy Clin ment, and considerations for the fu-
North Am. 2017 Nov;37(4):727-49. ture. Am J Rhinol Allergy. 2016 Nov-
7. Doña I, Barrionuevo E, Salas M, et al. Dec;30(6):407-13.
NSAIDs-hypersensitivity often induc-
es a blended reaction pattern involv- 15. Rajan JP, Wineinger NE, Stevenson
ing multiple organs. Sci Rep. 2018 Nov DD, et al Prevalence of aspirin-exacer-
12;8(1):16710. doi: 10.1038/s41598-018- bated respiratory disease among asth-
34668-1. matic patients: A meta-analysis of the
8. Doña I, Pérez‐Sánchez N, Eguiluz‐Gra- literature. J Allergy Clin Immunol.
cia I, et al. Progress in understanding 2015 Mar;135(3):676-81.e1.
hypersensitivity reactions to nonsteroi-
dal anti‐inflammatory drugs. Allergy. 16. Makowska JS, Burney P, Jarvis D, et al.
2020 Mar;75(3):561-75. Respiratory hypersensitivity reactions
9. Kowalski ML, Makowska JS. Seven to NSAIDs in Europe: the global aller-
steps to the diagnosis of NSAIDs Hy- gy and asthma network (GA 2 LEN)
persensitivity: how to apply a new clas- survey. Allergy. 2016 Nov;71(11):1603-
sification in real practice? Allergy Asth- 11.
ma Immunol Res. 2015 Jul;7(4):312-20.
17. Taniguchi M, Mitsui C, Hayashi H,
et al. Aspirin-exacerbated respirato-
ry disease (AERD): Current under-
standing of AERD. Allergol Int. 2019
Jul;68(3):289-95.
18. Szczeklik A, Nizankowska E, Dupla-
ga M. Natural history of aspirin-in-
note on aspirin desensitization). By F. et al. Contribution of aspirin-intoler-
severe asthma forum 1: severe asthma - basic and clinical views Widal, P. Abrami, J. Lermoyez. J Asth- ant asthma to near fatal asthma based
ma. 1987;24(5):297-300. on a questionnaire survey in Niigata
2. Mascia K, Haselkorn T, Deniz YM, et Prefecture, Japan. Respirology. 2005
al. Aspirin sensitivity and severity of Sep;10(4):477-84.
asthma: evidence for irreversible airway
obstruction in patients with severe or 11. Kowalski ML. Heterogeneity of
difficult-to-treat asthma. J Allergy Clin NSAID-Exacerbated Respiratory Dis-
Immunol. 2005 Nov;116(5):970-5. ease: has the time come for subpheno-
3. Wöhrl S. NSAID hypersensitivity – rec- typing? Curr Opin Pulm Med. 2019
ommendations for diagnostic work up Jan;25(1):64-70.
and patient management. Allergo J Int.
2018;27(4):114-21. 12. Kowalski ML, Agache I, Bavbek S,
4. Blanca-Lopez N, Soriano V, Gar- et al. Diagnosis and management of
cia-Martin E, et al. NSAID-induced re- NSAID‐Exacerbated Respiratory Dis-
actions: Classification, prevalence, im- ease (N-ERD) – a EAACI position pa-
pact, and management strategies. J per. Allergy. 2019 Jan;74(1):28-39.
Asthma Allergy. 2019 Aug 8;12:217-33.
5. Kowalski ML, Asero R, Bavbek S, 13. Stevenson DD, White AA. Clinical
et al. Classification and practical ap- Characteristics of Aspirin-Exacerbated
proach to the diagnosis and manage- Respiratory Disease. Immunol Allergy
ment of hypersensitivity to nonsteroidal Clin North Am. 2016 Nov;36(4):643-
anti-inflammatory drugs. Allergy. 2013 55.
Oct;68(10):1219-32.
6. Modena B, White AA, Woessner KM. 14. Kennedy JL, Stoner AN, Borish L.
Aspirin and Nonsteroidal Antiinflam- Aspirin-exacerbated respiratory dis-
matory Drugs Hypersensitivity and ease: Prevalence, diagnosis, treat-
Management. Immunol Allergy Clin ment, and considerations for the fu-
North Am. 2017 Nov;37(4):727-49. ture. Am J Rhinol Allergy. 2016 Nov-
7. Doña I, Barrionuevo E, Salas M, et al. Dec;30(6):407-13.
NSAIDs-hypersensitivity often induc-
es a blended reaction pattern involv- 15. Rajan JP, Wineinger NE, Stevenson
ing multiple organs. Sci Rep. 2018 Nov DD, et al Prevalence of aspirin-exacer-
12;8(1):16710. doi: 10.1038/s41598-018- bated respiratory disease among asth-
34668-1. matic patients: A meta-analysis of the
8. Doña I, Pérez‐Sánchez N, Eguiluz‐Gra- literature. J Allergy Clin Immunol.
cia I, et al. Progress in understanding 2015 Mar;135(3):676-81.e1.
hypersensitivity reactions to nonsteroi-
dal anti‐inflammatory drugs. Allergy. 16. Makowska JS, Burney P, Jarvis D, et al.
2020 Mar;75(3):561-75. Respiratory hypersensitivity reactions
9. Kowalski ML, Makowska JS. Seven to NSAIDs in Europe: the global aller-
steps to the diagnosis of NSAIDs Hy- gy and asthma network (GA 2 LEN)
persensitivity: how to apply a new clas- survey. Allergy. 2016 Nov;71(11):1603-
sification in real practice? Allergy Asth- 11.
ma Immunol Res. 2015 Jul;7(4):312-20.
17. Taniguchi M, Mitsui C, Hayashi H,
et al. Aspirin-exacerbated respirato-
ry disease (AERD): Current under-
standing of AERD. Allergol Int. 2019
Jul;68(3):289-95.
18. Szczeklik A, Nizankowska E, Dupla-
ga M. Natural history of aspirin-in-
